C. Bal (Wien, Austria), S. Dortas Junior (Rio De Janeiro (RJ), Brazil)
Clinical characteristics of adult obese asthma with type-2 inflammation dominant
M. To (Koshigaya, Japan), R. Tsuzuki (Tokyo, Japan), S. Yamawaki (Tokyo, Japan), N. Honda (Koshigaya, Japan), I. Kano (Koshigaya, Japan), K. Haruki (Koshigaya, Japan), Y. To (Tokyo, Japan)
|   |
PD40 sGaw with deep inhalation as alternative for PD20 FEV1
L. Natalia (Amsterdam, Netherlands), M. Van Der Plas (The Hague, Netherlands), P. Bresser (Amsterdam, Netherlands)
| |
FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients
H. Haagensen Andersen (Aarhus, Denmark), M. Mousa (Aarhus, Denmark), N. Mousa (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), J. Schmid (Aarhus, Denmark)
| |
The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma
F. Alabi (Celebration, United States of America), C. Alabi (Celebration, United States of America), H. Alkhateeb (Celebration, United States of America), M. Zibanayi (Celebration, United States of America), M. Zeper (Celebration, United States of America), K. Garcia (Celebration, United States of America), A. Oderinde (Celebration, United States of America)
| |
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers
S. SINGH (LUCKNOW, India), S. Kumar (LUCKNOW, India), S. Verma (LUCKNOW, India)
| |
The impact of depression in patients with severe asthma (SA) in the Wessex Severe Asthma Cohort (WSAC)
L. Wiffen (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Fox (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), H. Rupani (Portsmouth, United Kingdom), S. Elliott (Portsmouth, United Kingdom), A. Chauhan (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom)
| |
Non-eosinophilic COPD is associated with severe emphysema assessed by quantitative computed tomography
K. Chen (Taipei, Taiwan), H. Kuo (Taipei, Taiwan), S. Ho (Taipei, Taiwan), K. Lee (Taipei, Taiwan)
| |
Evaluation of the effect of excess body weight on the level of pro-inflammatory cytokines in patients with asthma-COPD overlap.
S. Faletrova (Ryazan (Ryazan Oblast), Russian Federation), O. Uryasev (Ryazan (Ryazan Oblast), Russian Federation), E. Belskikh (Ryazan (Ryazan Oblast), Russian Federation), L. Nikiforova (Ryazan (Ryazan Oblast), Russian Federation)
| |
Time trends in prevalence of symptoms of asthma in Indian children: ISAAC and GAN studies
S. Singh (Jaipur (Rajasthan), India), S. Salvi (Pune, India), S. Awasthi (Lucknow, India), N. Singh (Jaipur, India), M. Barne (Pune, India), M. Singh (ChandigarhPune, India), S. Mohammad (Bikaner, India), S. Kocher (Bikaner, India), S. Kabra (New Delhi, India), S. Sinha (New Delhi, India), A. Ghoshal (Kolkata, India), T. Sukumaran (Kottayam, India), P. Mahesh (Mysore, India), D. Mangal (Jaipur, India), V. Singh (Jaipur, India)
| |
Differences between early-onset persistent and late-onset asthma: a real life study
M. TURRIN (Padova, Italy), S. Baraldo (Padova, Italy), K. Lokar Oliani (Padova, Italy), M. Rizzo (Padova, Italy), F. Lionello (Padova, Italy), E. Bazzan (Padova, Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy)
| |
Impulse Ocscillometry is a reproducible assessment of airway resistance and reactance in well-controlled asthmatics and healthy controls.
L. Moelgaard Pedersen (Århus, Denmark), N. Mousa (Århus, Denmark), M. Mousa (Århus, Denmark), H. Andersen (Århus, Denmark), A. Bjerrum (Århus, Denmark), T. Skjold (Århus, Denmark), H. Hoffmann (Århus, Denmark), J. Schmid (Århus, Denmark)
| |
Indoor home allergen load relates to clinical outcomes in COPD: A metagenomics approach
P. Tiew (Singapore, Singapore), T. Jaggi (Singapore, Singapore), M. Mac Aogain (Singapore, Singapore), J. Lau (Singapore, Singapore), F. Ivan (Singapore, Singapore), N. Gaultier (Singapore, Singapore), M. Koh (Singapore, Singapore), T. Ong (Singapore, Singapore), F. Chew (Singapore, Singapore), S. Schuster (Singapore, Singapore), S. Chotirmall (Singapore, Singapore)
| |
Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease
N. Obling (Næstved, Denmark), V. Backer (Copenhagen, Denmark), J. Hurst (London, United Kingdom), U. Bodtger (Næstved, Denmark)
| |
Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study
R. Athanazio (São Paulo, Brazil), R. Stelmach (São Paulo, Brazil), M. Antila (São Paulo, Brazil), A. Machado (São Paulo, Brazil), L. Arruda (São Paulo, Brazil), A. Neto (São Paulo, Brazil), F. Cerpa (São Paulo, Brazil), D. Blanco (São Paulo, Brazil), M. Lima (São Paulo, Brazil), M. Rabahi (São Paulo, Brazil), P. Bianchi (São Paulo, Brazil), L. Furlan (São Paulo, Brazil), A. Santa Maria (São Paulo, Brazil), F. Lopes (São Paulo, Brazil), A. Souza (São Paulo, Brazil), M. Penha (São Paulo, Brazil)
| |
Application of machine learning algorithms to predict loss of asthma control: A post-hoc analysis of INCONTRO study
S. Necander (Gothenburg, Sweden), A. Teixeira (Cambridge, United Kingdom), V. Chaudhuri (Cambridge, United Kingdom), M. Hashemi (Gothenburg, Sweden), R. Pálmer (Gothenburg, Sweden), K. Korsback (Gothenburg, Sweden), C. Pedrinaci (Cambridge, United Kingdom), I. Psallidas (Cambridge, United Kingdom)
| |
Features of the chemiluminescent activity of neutrophils in chronic obstructive pulmonary disease associated with multiple myeloma
O. Smirnova (Krasnoyarsk, Russian Federation)
| |
Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD)
M. Pilaczynska-Cemel (Bydgoszcz, Poland), R. Golada (Bydgoszcz, Poland), A. Dabrowska (Bydgoszcz, Poland), T. Wandtke (Bydgoszcz, Poland), G. Przybylski (Bydgoszcz, Poland)
| |
Serum Interleukin (IL)-6 levels in patients with severe asthma disease is associated with blood eosinophilia
A. Singla (Essen, Germany), F. Engbert (Essen, Germany), H. Kas (Essen, Germany), F. Funke (Essen, Germany), I. Haasler (Essen, Germany), H. Beckert (Essen, Germany), S. Reuter (Essen, Germany), C. Taube (Essen, Germany)
| |